Delaware Chapter of the American College of CardiologyOur purpose is to contribute to the prevention of cardiovascular diseases, to ensure optimal quality of care for individuals with such diseases, and to foster the highest professional ethical standards. Please let us know what information you want to see here. Feel free to contact us with your ideas, needs and comments. |
|
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Latest in Cardiology from ACC.org
- GBD Study 2023: Myocarditis Burden Rising Despite Decline in DALYs, Mortality RatesDespite declines in disability-adjusted life years (DALYs) and mortality rates from myocarditis globally from 1990 to 2023, its incidence and prevalence remained stable, suggesting improvements in disease outcomes over time, according to a study using data from the GBD (Global Burden of Disease, Injuries, and Risk Factors Study) 2023 and published Sept. 2 in JACC.
- Novel LA Staging Framework Stratifies NOAF Risk in HCMA novel left atrium (LA) staging framework proposed by Jaehyun Lim, MD, PhD, et al., was independently associated with a significant, stepwise increase in risk of new-onset atrial fibrillation (NOAF) in patients with hypertrophic cardiomyopathy (HCM), providing incremental predictive value beyond established atrial fibrillation (AFib) risk models, and may help tailor AFib surveillance strategies for […]
- AI-Enabled Clinician: Practical Frameworks for Monitoring AI ToolsIn this episode, Dr. Ami Bhatt speaks with Dr. Sneha Jain about evaluating and monitoring artificial intelligence tools for clinical practice.
- State-of-the-Art Review Proposes Changes to Current CV Subspecialty Training ModelAs cardiovascular subspecialties continue to grow, deficiencies have been exposed in the current training model. A recent State-of-the-Art Review published in JACC: Advances reviews the current training model and how it is being redefined and proposes new training models that can help meet the growing needs of trainees, programs, patients and health care institutions.
- ALL-RISE: Angiography-Derived Physiology Simplifies PCI Without Compromising OutcomesThe ALL-RISE (Advancing Cath Lab Results with FFRangio Coronary Physiology Assessment) trial results demonstrated that, among patients with intermediate coronary stenoses undergoing invasive angiography, an angiography-derived fractional flow reserve (FFRangio [Medtronic]) strategy was noninferior to pressure wire–based physiological assessment for death, myocardial infarction, or unplanned clinically indicated revascularization at 1 year.



